[Prostaglandins and thromboxane in coronary arteriosclerosis].
The prostanoid status was assessed in 138 patients with coronary atherosclerosis and clinical signs of stable angina. Plasma prostaglandin F2 alpha and E1, and stable prostacyclin and thromboxane metabolites were measured radioimmunologically, using standard kits. A relationship is demonstrated between the severity of clinical manifestations, and pattern and magnitude of change in individual prostanoids.
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000031:analogs & derivatives / Q000097:blood; D003324:Coronary Artery Disease / Q000097:blood*; D015237:Dinoprost; D015232:Dinoprostone; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011458:Prostaglandins E / Q000097:blood*; D011460:Prostaglandins F / Q000097:blood*; D013929:Thromboxane B2 / Q000097:blood*
D011458:Prostaglandins E; D011460:Prostaglandins F; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C022950:6-ketoprostaglandin E1; D015237:Dinoprost; D000527:Alprostadil; D015232:Dinoprostone
Prostaglandiny i tromboksan pri koronarnom ateroskleroze.